JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266409

Human SSNA1 knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

SSNA1 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 1. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
1 Images
Sanger Sequencing - Human SSNA1 knockout HEK-293T cell line (AB266409)
  • Sanger seq

Unknown

Sanger Sequencing - Human SSNA1 knockout HEK-293T cell line (AB266409)

Homozygous : 1 bp insertion in exon1

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 1

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266409-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266409 Human SSNA1 knockout HEK-293T cell line", "number":"AB266409-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266409-CMP02" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266409-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266409 Human SSNA1 knockout HEK-293T cell line", "number":"AB266409-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266409-CMP02" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266409-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266409 Human SSNA1 knockout HEK-293T cell line", "number":"AB266409-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266409-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266409 Human SSNA1 knockout HEK-293T cell line", "number":"AB266409-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
SSNA1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

SSNA1 also known as sperm-specific antigen 1 is a protein that plays a mechanical role in cellular functions. It weighs approximately 16 kDa and is expressed predominantly in testicular tissue but can also find expression in other tissues like the brain. SSNA1 operates by facilitating the polymerization of microtubules which are structures critical for maintaining cell shape and enabling cell division. This protein associates with microtubules within cells suggesting a role in the regulation of cytoskeleton dynamics.
Biological function summary

SSNA1 serves functions beyond those of structural support and microtubule association. It acts as a part of the microtubule-associated complex which is integral in cellular transport and mitosis processes. SSNA1 contributes to intracellular cargo transport by supporting the movement of cargo along the microtubule network. Its association in the microtubule complex emphasizes its significance in maintaining a balance of assembly and disassembly of cellular structures for regular cell functioning and division.

Pathways

SSNA1 plays a role in the cytoskeleton signaling pathway notably by interacting with key regulators such as tubulin and microtubule-associated proteins. It's involved in processes such as cell cycle regulation particularly during mitosis. SSNA1's interaction with these proteins implies a contributory role in checkpoint controls that ensure correct cell division. Additionally SSNA1 has an influence on signal transduction pathways that govern cell shape and motility. It works in conjunction with pathways like the MAPK signaling pathway which is central to cellular responses to stress and proliferative signals.

Alterations in SSNA1 expression or function have links to certain neurological conditions. SSNA1 has an association with neurodegenerative diseases where its interaction with proteins such as tau can influence tauopathy conditions possibly due to its involvement in microtubule stability. Another condition linked to SSNA1 is Klinefelter syndrome where its overexpression or irregular activity can lead to symptoms associated with testicular abnormalities. Further studies can aid in understanding how SSNA1 impacts the pathogenesis of these disorders and might provide insights into potential therapeutic targets.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com